SeriesA

 

 

Hosted by      Morgan-Prestwich-Logo  

 

SERIES A FINANCE RAISE OF THE YEAR

This award recognises a company that has successfully completed a significant, impactful or transformational private fundraise at Series A level.

It is open to private European life science companies only.

Qualifying criteria

- Must be a fundraise by a private company
- Must have raised the funds in the period between 1 September 2018 and 1 September 2019
- Must be a company with European headquarters

Judges will be paying particular attention to:
 
- Amount of funds raised
- Process / speed / allocation fulfilment of securing of significant new funds
- Level / reputation of investors attracted / reputation of investors reinvesting
- Post-finance allocation / use of proceeds
- Level of value creation / value realisation from raise
 
 

2019 WINNER

 

Arvelle-01-1

 

 

(L-R) Greg Bell, CEO, Morgan Prestwich, Mark Altmeyer, CEO, Arvelle Therapeutics, Greg Weinhoff, Co-Founder, CFO & CBO, Arvelle Therapeutics and Ellie Taylor, Emcee

 

 

2019 HIGHLY COMMENDED

 
 
Quell-01-1
 

 

ALL 2019 FINALISTS

 

Arvelle Therapeutics

ARVELLE THERAPEUTICS, SWITZERLAND

CAMLE-IDS

CAMEL-IDS, BELGIUM

Confo Therapeutics

CONFO THERAPEUTICS, BELGIUM

Grey Wolf Therapeutics

GREY WOLF THERAPEUTICS, UNITED KINGDOM

Omass Therapeutics

OMASS THERAPEUTICS, UNITED KINGDOM

Quell Therapeutics

QUELL THERAPEUTICS, UNITED KINGDOM

SNIPR Biome

SNIPR BIOME, DENMARK

Storm Therapeutics

STORM THERAPEUTICS, UNITED KINGDOM

BUY TICKETS AND TABLES